An Introduction to Policy
Cancer care is a challenging but fast-evolving field, and clear policies must be available for healthcare professionals, societies and patients. The European Cancer Organisation strives to bring impactful policy improvement by bringing together the oncology community and facilitating collaboration and consensus on important issues within cancer care. touchOCNOLOGY has collaborated with the European Cancer Organisation to produce video content and short articles to address the important policy issues within cancer care.
Our supporting partners do not constitute an endorsement of the content on this page.
ASH ANNUAL MEETING & EXPOSITION 2023, San Diego
We’re looking forward to the upcoming ASH Annual Meeting & Exposition 2023 which is taking place in San Diego between 9 – 12 December.
ESMO Congress 2023, Madrid, Spain
We’re looking forward to the upcoming ESMO Congress 2023 which is taking place in Madrid between 20-24 October. Promising attendees an opportunity to explore the latest technologies, treatments and products in the field of Oncology, we are excited to be there in-person to provide independent, expert video coverage of key data. You can sign-up […]
Raising awareness around HPV infection, cancer risk and vaccination: PrEvCan | Daniel Kelly
The PrEvCan – Cancer Prevention Across Europe – campaign, initiated by the European Oncology Nursing Society (EONS) and supported by ESMO, aims to reduce the burden of cancer by promoting a different way we can decrease cancer risk each month. This August, the PrEvCan campaign focuses on raising awareness about the connection between human papillomavirus […]
Vivek Subbiah, AACR 2023: The purpose of phase I clinical trials
The purpose of phase I clinical trials are to evaluate the safety, dosage and potential side effects of a new drug or treatment in humans for the first time. In this touchONCOLOGY interview, we speak with Dr Vivek Subbiah (University of Texas, MD Anderson Cancer Centre, Houston, TX, USA) to discuss the purpose and details […]
Vivek Subbiah, AACR 2023: The evolution of phase I clinical trials in the era of precision medicine
Precision medicine aims to tailor medical treatments to individual patients based on their characteristics and genetic makeup. Phase I clinical trials are seeing changes in their objectives and designs in the era of precision medicine. In this touchONCOLOGY interview, we speak with Dr Vivek Subbiah (University of Texas, MD Anderson Cancer Centre, Houston, TX, USA) […]
Navigating HRT and cancer risk: PrEvCan | Celia Diez de los Rios
This July, the PrEvCan campaign is dedicated to raising awareness about women’s cancer risk in connection with breastfeeding and hormone replacement therapy (HRT). Initiated by the European Oncology Nursing Society (EONS), and with ESMO as a key campaign partner, the PrEvCan – Cancer Prevention Across Europe – campaign, is aimed at reducing the burden of […]
Cancer prevention and the power of breastfeeding: PrEvCan | Celia Diez de los Rios
The relationship between breastfeeding and a reduction in cancer risk is the focus of the PrEvCan Campaign, this July. Initiated by the European Oncology Nursing Society (EONS), and with ESMO as a key campaign partner, the PrEvCan – Cancer Prevention Across Europe – campaign, is aimed at reducing the burden of cancer. In this interview […]
Helena Ullgren: PrEvCan | Focus on alcohol and cancer prevention
The European Code Against Cancer (ECAC) recommends that if you drink alcohol of any type you should limit your intake and that not drinking alcohol is best for cancer prevention. This March, the PrEvCan campaign, spearheaded by EONS to promote cancer prevention across Europe, is bringing attention to the link between alcohol consumption and cancer […]
Pompiliu Piso: ESSO Oncopolicy – cross-multidisciplinary training in oncology at the EU level (Part 2)
The European Society of Surgical Oncology (ESSO), along with other cancer-related European societies, supported the proposal for cross-multidisciplinary training in oncology at the EU level. It was a pleasure to talk with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, Regensburg, Germany) to discuss how cross-multidisciplinary training would affect cancer care in Europe and the other initiatives […]